Minister: Sultanate seeks to obtain 700,000 doses of medication following its production

Also In This Package
Asian countries resume lockdown as infections spike
Look which European leader wears the mask the best
Look how American schools plan for a September restart
Diners maintain social distancing with teddy bears
COVID-19: People show how not to wear a mask in India
COVID-19: Tokyo Olympics depend on treatment
Cairo: Oman is seeking to obtain 700,000 doses of a new vaccine treating the new coronavirus once it is produced, Health Minister Dr Ahmed Al Saeed has said.
Oman is fighting to curb the spread of the potentially fa-tal disease. The sultanate so far has reported a total of 77,058 virus cases and 393 related fatalities.
Also Read
Oman Post launches new stamps commemorating country's musical legacyPhotos: Readers' choice - Best travel destinations in Pakistan, India, Georgia, Azerbaijan and Oman From Novak Djokovic to Roger Federer, the starry social media lives of tennis starsIn pictures: World leaders in Oman to mourn Sultan Qaboos"There is constant and continued coordination between the sultanate represented by the Health Ministry and the Global Alliance for Vaccines and Immunisation (GAVI) to obtain 700,000 doses of the anti-coronavirus vaccine fol-lowing its production," Dr Al Saeed told the Omani news agency ONA.
He added that his ministry is acting at several levels to get the vaccine after its safety and effectiveness are ver-ified. "The sultanate seeks participation in developing research related to this vaccine to guarante the right to obtain it once it is manufactured," he added without giv-ing details.
In recent weeks, Oman has seen a spike in the virus in-fections, prompting authorities to tighten preventive measures.
The country began this week enforcing a full lockdown among its governorates for two weeks, including the Eid Al Adha holiday, in an effort to curb the spread of the pandemic.
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox
Network Links
GN StoreDownload our app
© Al Nisr Publishing LLC 2026. All rights reserved.